HKD 1.11
(-4.31%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 58.18 Million USD | 16.72% |
2022 | 49.64 Million USD | 21.27% |
2021 | 40.94 Million USD | 71.23% |
2020 | 23.91 Million USD | 29.5% |
2019 | 18.46 Million USD | -11.4% |
2018 | 20.83 Million USD | 86.9% |
2017 | 11.14 Million USD | 25.48% |
2016 | 8.88 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 32.15 Million USD | 0.0% |
2023 Q4 | 27.69 Million USD | 0.0% |
2023 Q2 | 29.27 Million USD | 0.0% |
2023 FY | 57.94 Million USD | 16.72% |
2022 FY | 49.64 Million USD | 21.27% |
2022 Q2 | 25.1 Million USD | 0.0% |
2022 Q4 | 24.54 Million USD | 0.0% |
2021 Q2 | 17.94 Million USD | 0.0% |
2021 FY | 40.94 Million USD | 71.23% |
2021 Q4 | 23 Million USD | 0.0% |
2020 Q4 | 12.89 Million USD | 0.0% |
2020 Q2 | 11.01 Million USD | 0.0% |
2020 FY | 23.91 Million USD | 29.5% |
2019 Q4 | 9.43 Million USD | 0.0% |
2019 FY | 18.46 Million USD | -11.4% |
2019 Q2 | 9.02 Million USD | 0.0% |
2018 Q2 | 10.32 Million USD | 0.0% |
2018 Q4 | 9.25 Million USD | 0.0% |
2018 FY | 20.83 Million USD | 86.9% |
2017 Q1 | 2.78 Million USD | 0.0% |
2017 FY | 11.14 Million USD | 25.48% |
2017 Q4 | 5.2 Million USD | 0.0% |
2017 Q2 | 2.78 Million USD | 0.0% |
2016 Q4 | 2.78 Million USD | 0.0% |
2016 FY | 8.88 Million USD | 0.0% |
2016 Q1 | 2.22 Million USD | 0.0% |
2016 Q2 | 2.22 Million USD | 0.0% |
2015 Q4 | 2.22 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Uni-Bio Science Group Limited | 325.05 Million HKD | 82.1% |
CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | 92.129% |